Posted inMarket
Definium Therapeutics CEO Robert Barrow Sells Over $721K in Company Shares
Definium Therapeutics CEO Robert Barrow recently executed a stock sale totaling $721,732. Learn the details of this executive transaction.
Posted inMarket
BioCardia CEO Peter Altman Purchases Company Stock
BioCardia CEO Peter Altman recently acquired shares of company stock, reflecting ongoing leadership involvement in the biotech firm.
